ArticleAnnals of translational medicine2020

Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma: Acknowledgments.

Diamantis I Tsilimigras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.